206 related articles for article (PubMed ID: 22007948)
1. Long-term treatment of severe SAPHO syndrome with adalimumab: case report and a review of the literature.
Garcovich S; Amelia R; Magarelli N; Valenza V; Amerio P
Am J Clin Dermatol; 2012 Feb; 13(1):55-9. PubMed ID: 22007948
[TBL] [Abstract][Full Text] [Related]
2. SAPHO syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report.
Luzzati M; Simonini G; Filippeschi C; Giani T; Trapani S
Ital J Pediatr; 2020 Nov; 46(1):169. PubMed ID: 33187546
[TBL] [Abstract][Full Text] [Related]
3. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature.
Vekic DA; Woods J; Lin P; Cains GD
Int J Dermatol; 2018 Jan; 57(1):10-18. PubMed ID: 28884797
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate.
Genovese G; Caorsi R; Moltrasio C; Marzano AV
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():40-41. PubMed ID: 31535768
[TBL] [Abstract][Full Text] [Related]
5. Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab.
Iqbal M; Kolodney MS
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S118-20. PubMed ID: 15858507
[TBL] [Abstract][Full Text] [Related]
6. Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature.
Moll C; Hernández MV; Cañete JD; Gómez-Puerta JA; Soriano A; Collado A; Sanmartí R
Semin Arthritis Rheum; 2008 Apr; 37(5):299-306. PubMed ID: 17976692
[TBL] [Abstract][Full Text] [Related]
7. Gingival pustules and sterile diffuse sclerosing osteomyelitis as a feature of synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.
Chou A; Schulman JM; Gross AJ; Jordan RC; Ramos DM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 May; 121(5):e116-22. PubMed ID: 26619759
[TBL] [Abstract][Full Text] [Related]
8. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations.
Massara A; Cavazzini PL; Trotta F
Rheumatology (Oxford); 2006 Jun; 45(6):730-3. PubMed ID: 16403830
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha blockers in SAPHO syndrome.
Ben Abdelghani K; Dran DG; Gottenberg JE; Morel J; Sibilia J; Combe B
J Rheumatol; 2010 Aug; 37(8):1699-704. PubMed ID: 20472920
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of pediatric synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: the first Chinese case series from a single center.
Wu N; Shao Y; Huo J; Zhang Y; Cao Y; Jing H; Zhang F; Yu C; Yu Y; Li C; Song H; Zhang W
Clin Rheumatol; 2021 Apr; 40(4):1487-1495. PubMed ID: 32929648
[TBL] [Abstract][Full Text] [Related]
11. Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome complicated by seven pulmonary emboli in a 15-year old patient.
Coloe J; Diamantis S; Henderson F; Morrell DS
J Am Acad Dermatol; 2010 Feb; 62(2):333-6. PubMed ID: 20115954
[TBL] [Abstract][Full Text] [Related]
12. [Dermatologic aspects of SAPHO-syndrome].
Károlyi Z; Harhai I; Erós N
Orv Hetil; 2001 Aug; 142(33):1801-4. PubMed ID: 11573450
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata.
Liu S; Wu X; Cao Y; Li Z; Liu Y; Ma M; Li C
Pediatr Rheumatol Online J; 2022 Oct; 20(1):88. PubMed ID: 36224598
[TBL] [Abstract][Full Text] [Related]
14. Biological treatments for SAPHO syndrome: an update.
Firinu D; Murgia G; Lorrai MM; Barca MP; Peralta MM; Manconi PE; del Giacco SR
Inflamm Allergy Drug Targets; 2014; 13(3):199-205. PubMed ID: 24846337
[TBL] [Abstract][Full Text] [Related]
15. SAPHO syndrome in an adolescent: a clinical case with unusual severe systemic impact.
Freira S; Fonseca H; Ferreira PD; Vasconcelos P; Fonseca JE
J Adolesc Health; 2014 Aug; 55(2):304-6. PubMed ID: 24726464
[TBL] [Abstract][Full Text] [Related]
16. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with review of the relevant published work.
Zhao Z; Li Y; Li Y; Zhao H; Li H
J Dermatol; 2011 Feb; 38(2):155-9. PubMed ID: 21269311
[TBL] [Abstract][Full Text] [Related]
17. SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.
Firinu D; Garcia-Larsen V; Manconi PE; Del Giacco SR
Curr Rheumatol Rep; 2016 Jun; 18(6):35. PubMed ID: 27108452
[TBL] [Abstract][Full Text] [Related]
18. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients.
Amital H; Applbaum YH; Aamar S; Daniel N; Rubinow A
Rheumatology (Oxford); 2004 May; 43(5):658-61. PubMed ID: 14983108
[TBL] [Abstract][Full Text] [Related]
19. SAPHO: has the time come for tailored therapy?
Figueiredo ASB; Oliveira AL; Caetano A; Moraes-Fontes MF
Clin Rheumatol; 2020 Jan; 39(1):177-187. PubMed ID: 31312988
[TBL] [Abstract][Full Text] [Related]
20. SAPHO syndrome in childhood. A case report.
Vargas Pérez M; Sevilla Pérez B
Reumatol Clin (Engl Ed); 2018; 14(2):109-112. PubMed ID: 27993538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
